Trademark: QUANTUMDX 2303925
Word
QUANTUMDX
ID
2303925
Trademark Type
WORD
Status
Accepted: In opposition period
Application Date
28 April 2022

Service
IP Gateway Patent & Trade Mark Attorneys Pty Ltd

Goods and Services:
Class 10:
Medical, veterinary, pharmaceutical and clinical diagnostic devices, apparatus, tools and instruments; medical point of care diagnostic testing devices, apparatus, tools and instruments; medical apparatus for monitoring, tracking and mapping of diseases, viruses and pathogens; molecular diagnostic devices for medical veterinary, pharmaceutical and clinical purposes; devices for sample testing and drug sensitivity testing for medical veterinary, pharmaceutical and clinical purposes; medical body fluid and sample testing apparatus; apparatus for diagnosis, examination, monitoring and treatment of diseases; microbiological analysis, detection, screening and testing apparatus; apparatus for detecting and identifying biological agents, genetic material and microorganisms; apparatus and instruments for use in screening and testing biological samples, microbiological samples and viral samples; screening and testing apparatus for medical purposes, for sale in kit form; micro-array kits for detecting and identifying biological agents, genetic material and microorganisms; micro-array apparatus and micro-array testing kits for medical purposes; medical equipment and devices incorporating a cartridge for sample preparation, nucleic acid purification, nucleic acid amplification and optical detection; medical equipment in the nature of instrument systems, containers and reaction vessels for preparing and processing biological samples; medical apparatus and instruments including bench-top or hand-held readers and microfluidic cartridges; medical consumables and supplies; medical, veterinary, pharmaceutical and clinical apparatus for detecting, identifying, testing and analysing DNA, RNA, proteins, peptides, hormones, metabolic markers and sugars; medical, veterinary, pharmaceutical and clinical apparatus and instruments, equipment and devices for use in DNA, RNA and polynucleic acid sequencing, testing and detection; medical, veterinary, pharmaceutical and clinical apparatus, instruments, equipment and devices for use in detection of proteins, peptides, sugars or metabolites; micro-array apparatus for sequencing, DNA detection, RNA detection, melt detection (nucleic acids), protein detection, peptide detection, sugar detection and metabolite detection, all for medical purposes; portable medical, veterinary, pharmaceutical and clinical apparatus and instruments for biological, bacteriological, chemical, biochemical and molecular analysis; medical, veterinary, pharmaceutical and clinical sensors and electronic sensing apparatus for detecting and identifying DNA, RNA, proteins, peptides, hormones, metabolic markers and sugars; medical, veterinary, pharmaceutical and clinical apparatus, devices and instruments for identifying, measuring, analysing, sequencing or synthesising small molecules, genomes, DNA, RNA or other nucleic acids, proteins, peptides, hormones, metabolic markers and sugars; medical, veterinary, pharmaceutical and clinical apparatus and instruments for use in DNA, RNA, protein and polynucleic acid sequencing; diagnostic and testing apparatus, for medical purposes.
Class 44:
Medical diagnostic services; medical screening and testing services; medical monitoring and reporting services; medical services in the nature of monitoring, tracking and mapping diseases, viruses and pathogens for medical purposes; data collection and reporting relating to disease incidence and drug resistance; optical imaging for medical diagnostic use; medical testing for diagnostic or treatment purposes; diagnostic testing for medical diagnosis or treatment purposes; medical testing services for diagnosis or treatment of diseases; providing online information relating to disease treatment and prevention; managed healthcare services; disease management intervention services; medical data services; DNA testing, screening, extraction and purification services for medical purposes; medical evaluation services; medical point of care diagnostic testing services using a bench-top or hand-held reader, and microfluidic cartridges; medical screening, testing, monitoring, reporting and analysis services relating to genome sequencing; medical services in the nature of amplifying, labelling, detecting, analysing and sequencing nucleic acids; medical screening, testing, monitoring, reporting and analysis services relating to cells, tissues, gene expressions, gene and genome sequences, genome annotation, genome mapping, genome interaction and annotation, all for medical purposes; information, advisory and consultancy services relating to all the aforesaid services; medical screening.